BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17520566)

  • 1. A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration.
    Fealy N; Baldwin I; Johnstone M; Egi M; Bellomo R
    Int J Artif Organs; 2007 Apr; 30(4):301-7. PubMed ID: 17520566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Schilder L; Nurmohamed SA; Bosch FH; Purmer IM; den Boer SS; Kleppe CG; Vervloet MG; Beishuizen A; Girbes AR; Ter Wee PM; Groeneveld AB;
    Crit Care; 2014 Aug; 18(4):472. PubMed ID: 25128022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A
    Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study.
    Monchi M; Berghmans D; Ledoux D; Canivet JL; Dubois B; Damas P
    Intensive Care Med; 2004 Feb; 30(2):260-265. PubMed ID: 14600809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrate anticoagulation for continuous venovenous hemofiltration.
    Oudemans-van Straaten HM; Bosman RJ; Koopmans M; van der Voort PH; Wester JP; van der Spoel JI; Dijksman LM; Zandstra DF
    Crit Care Med; 2009 Feb; 37(2):545-52. PubMed ID: 19114912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial.
    Hetzel GR; Schmitz M; Wissing H; Ries W; Schott G; Heering PJ; Isgro F; Kribben A; Himmele R; Grabensee B; Rump LC
    Nephrol Dial Transplant; 2011 Jan; 26(1):232-9. PubMed ID: 20876598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
    Palsson R; Niles JL
    Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury.
    Liu DL; Huang LF; Ma WL; Ding Q; Han Y; Zheng Y; Li WX
    Chin Med J (Engl); 2016 Jul; 129(14):1682-7. PubMed ID: 27411455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous venovenous haemofiltration using a citrate buffered substitution fluid.
    Schmitz M; Taskaya G; Plum J; Hennersdorf M; Sucker C; Grabensee B; Hetzel GR
    Anaesth Intensive Care; 2007 Aug; 35(4):529-35. PubMed ID: 18020071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
    Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D
    Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A; Daul AE; Beiderlinden M; Schäfers RF; Heemann U; Kribben A; Peters J; Philipp T; Wenzel RR
    Clin Nephrol; 2003 Feb; 59(2):106-14. PubMed ID: 12608553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.
    Palsson R; Laliberte KA; Niles JL
    Clin Nephrol; 2006 Jan; 65(1):34-42. PubMed ID: 16429840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional anticoagulation and antiaggregation for CVVH in critically ill patients: a prospective, randomized, controlled pilot study.
    Fabbri LP; Nucera M; Al Malyan M; Becchi C
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):92-7. PubMed ID: 19650808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Liu C; Mao Z; Kang H; Hu J; Zhou F
    Crit Care; 2016 May; 20(1):144. PubMed ID: 27176622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose citrate continuous veno-venous hemofiltration (CVVH) and acid-base balance.
    Naka T; Egi M; Bellomo R; Cole L; French C; Wan L; Fealy N; Baldwin I
    Int J Artif Organs; 2005 Mar; 28(3):222-8. PubMed ID: 15818544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial.
    Ratanarat R; Phairatwet P; Khansompop S; Naorungroj T
    Blood Purif; 2023; 52(5):455-463. PubMed ID: 36858026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.
    Ong SC; Wille KM; Speer R; Tolwani AJ
    Int J Artif Organs; 2014 Jun; 37(6):499-502. PubMed ID: 24811309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation.
    van der Voort PH; Gerritsen RT; Kuiper MA; Egbers PH; Kingma WP; Boerma EC
    Blood Purif; 2005; 23(3):175-80. PubMed ID: 15711037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.